Biomedical Enterprises Inc

Biomedical Enterprises Inc. (BME) is a Maryland-based "C" corporation headquartered in Bethesda. As a small company with four employees, BME focuses on developing and commercializing medical devices. BME is dedicated to addressing unmet medical needs, particularly in the treatment of systemic infections that lack effective therapies. Their current focus is on a novel apparatus utilizing heat and ultraviolet light (UVL) to treat these infections. BME's founder, drawing on experience in dialysis and intensive care, identified this solution to address a significant clinical challenge. Previously, BME successfully developed and validated an innovative dialysis needle, the BME needle. This needle, supported by a $1.5 million grant from the National Institute of Health (NIH), demonstrated reduced damage to white blood cells, a lower release of pro-inflammatory cytokines, and diminished inflammation. This groundbreaking discovery earned the BME needle recognition and support through the NIH's commercialization assistance program. For more information about Biomedical Enterprises Inc. and its innovative medical devices, please visit their website at bmedialysis.com.